CompoAtlas

95% CLA 1250 Max Potency

Natural health product licensed in Canada

Other names
CLA 1250
Licence holder
Sports Research
NPN or DIN-HM
80089435
Status
Active licence
Licence date
5 December 2018
Revision date
13 November 2025
Form
Capsule, molle
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Eau purifiée, Glycérine, Poudre de caroube, Gélatine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule3 Tous les jours

Uses authorised in Canada

May help to support a modest reduction in fat mass and a modest improvement to body composition when used with a calorie-reduced diet and increased physical activity.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80089435

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line